SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001104659-22-117613
Filing Date
2022-11-14
Accepted
2022-11-14 06:50:42
Documents
54
Period of Report
2022-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10Q lptx-20220630x10q.htm   iXBRL 10-Q 1414532
2 EXHIBIT 31.1 lptx-20220630xex31d1.htm EX-31.1 15994
3 EXHIBIT 32.1 lptx-20220630xex32d1.htm EX-32.1 10398
  Complete submission text file 0001104659-22-117613.txt   5525916

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA lptx-20220630.xsd EX-101.SCH 36097
5 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE lptx-20220630_cal.xml EX-101.CAL 35911
6 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE lptx-20220630_def.xml EX-101.DEF 131124
7 XBRL TAXONOMY EXTENSION LABEL LINKBASE lptx-20220630_lab.xml EX-101.LAB 373223
8 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE lptx-20220630_pre.xml EX-101.PRE 249926
48 EXTRACTED XBRL INSTANCE DOCUMENT lptx-20220630x10q_htm.xml XML 938378
Mailing Address 47 THORNDIKE STREET SUITE B1-1 CAMBRIDGE MA 02142
Business Address 47 THORNDIKE STREET SUITE B1-1 CAMBRIDGE MA 02142 617 252 4343
LEAP THERAPEUTICS, INC. (Filer) CIK: 0001509745 (see all company filings)

IRS No.: 274412575 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37990 | Film No.: 221379974
SIC: 2834 Pharmaceutical Preparations